BioMathematica is building the new standard in the microbiome field: an online platform called the DryLab processing and integrating microbiome-related ‘omics’ data for condition specific, personalised microbiome models in healthy and disease states. Using Artificial Intelligence and genome-scale metabolic modelling, this platform is used by biotech and pharma companies for data analysis and diet–microbiome, microbe–microbe and host–microbe interactions simulations. The platform is dedicated to the development of personalised nutrition, prebiotics/probiotics/synbiotics and therapeutics design and optimization.
Co-Founder @ Biomathematica SAS
YOU MIGHT ALSO BE INTERESTED IN